Seysara
NDC 16110-245, sarecycline hydrochloride, tablet, coated, from Almirall, LLC.
- Product NDC
- 16110-245
- Status
- Listed
- Labeler
- Almirall, LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209521
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16110-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SARECYCLINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]; Tetracycline-class Drug [EPC]; Tetracyclines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16110-245-30 | 16110024530 | 30 TABLET, COATED in 1 BOTTLE (16110-245-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b200957c-3004-4988-be97-9fd619a83649
Use it
Look up 16110-245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16110-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16110-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.